Lightcast
2 known investors
Lightcast develops Envisia, a next-generation platform for single-cell functional screening and analysis that enables researchers to study biomolecule secretion, cell-cell interactions, and targeted cell killing at scale. The platform serves biotech and pharmaceutical companies working on therapeutic discovery and development.
AI & Machine LearningBiotechDeep Tech
Investors · 2
In the news
- US Data Release Notes | Lightcast Knowledge Basekb.lightcast.io · 2026
- Lightcast raises £19.9m in startup funding | Startupmagstartupmag.co.uk · 2026
- Lightcast Raises $27M to Advance Single-Cell Analysis - Ventureburnventureburn.com · 2026
- Lightcast Raises $27M in Fundingfinsmes.com · 2026
- Single-Cell Analysis Firm Lightcast Raises $27M | GenomeWebgenomeweb.com · 2026
- Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platformbusinesswire.com · 2026